Shares of Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.93 and traded as high as $2.95. Mesoblast shares last traded at $2.20, with a volume of 6,144 shares traded.
Mesoblast Price Performance
The business has a 50-day moving average of $1.28 and a 200 day moving average of $0.93.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
See Also
- Five stocks we like better than Mesoblast
- What is Short Interest? How to Use It
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What is the Dow Jones Industrial Average (DJIA)?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Insider Trades May Not Tell You What You Think
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
